| Rommel Gerardo Zerpa Alamo, MD | |
|
101 Page St, New Bedford, MA 02740-3464 | |
| (508) 973-5919 | |
| Not Available |
| Full Name | Rommel Gerardo Zerpa Alamo |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 10 Years |
| Location | 101 Page St, New Bedford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063919009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125072827 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice And Palliative Care | Fairhaven, MA | Hospice |
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southcoast Physicians Group Inc | 0749171957 | 746 |
News Archive
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company's experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.
Nearly all women who deliver babies through cesarean section at Columbia University Irving Medical Center in New York City receive injections of the blood thinner heparin for weeks after the procedure, to prevent potentially life-threatening blood clots.
Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the rates of expected and well known side effects.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 2 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company's experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.
Nearly all women who deliver babies through cesarean section at Columbia University Irving Medical Center in New York City receive injections of the blood thinner heparin for weeks after the procedure, to prevent potentially life-threatening blood clots.
Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the rates of expected and well known side effects.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rommel Gerardo Zerpa Alamo, MD 101 Page St, New Bedford, MA 02740-3464 Ph: (508) 973-5919 | Rommel Gerardo Zerpa Alamo, MD 101 Page St, New Bedford, MA 02740-3464 Ph: (508) 973-5919 |
News Archive
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company's experimental drug LX211 (LUVENIQ; oral voclosporin) will be featured in several presentations at the 2009 American Academy of Ophthalmology annual conference and American Uveitis Society meeting being held October 24-26 in San Francisco.
Nearly all women who deliver babies through cesarean section at Columbia University Irving Medical Center in New York City receive injections of the blood thinner heparin for weeks after the procedure, to prevent potentially life-threatening blood clots.
Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the rates of expected and well known side effects.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
› Verified 2 days ago
Efrain A Torres, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Brigham St, New Bedford, MA 02740 Phone: 508-979-1100 Fax: 508-979-1918 | |
Jeffrey James Bird, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Page St, New Bedford, MA 02740 Phone: 508-973-5919 Fax: 508-973-5916 | |
Dr. James Vincent Quinn, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 651 Orchard St, Suite 202a, New Bedford, MA 02744 Phone: 774-992-7058 Fax: 774-992-7061 | |
Thomas E Bozzo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 92 Grape St, New Bedford, MA 02740 Phone: 774-202-2264 | |
Dr. Irving Raul Restituyo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 726 County St, New Bedford, MA 02740 Phone: 917-703-0320 | |
Bahaa Aldeen Kaseer, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Page St, New Bedford, MA 02740 Phone: 508-973-5919 Fax: 508-973-5916 |